DNA Repair and Signaling in Immune-Related Cancer Therapy

Cancer therapy using immune checkpoint inhibitors (ICIs) is a promising clinical strategy for patients with multiple types of cancer. The expression of programmed cell death ligand-1 (PD-L1), an immune-suppressor ligand, in cancer cells is a factor that influences the efficacy of ICI therapy, partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakoti, Sangeeta, Sato, Hiro, Laskar, Siddhartha, Yasuhara, Takaaki, Shibata, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506057/
https://www.ncbi.nlm.nih.gov/pubmed/33102516
http://dx.doi.org/10.3389/fmolb.2020.00205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506057/
https://www.ncbi.nlm.nih.gov/pubmed/33102516
http://dx.doi.org/10.3389/fmolb.2020.00205

Ejemplares similares